Organisatie
Immunologie & Infectie
Sub-organisatie(s)
1 - 1 van 1
Huidige onderzoekers
1 - 10 of 106 results
- Philippe ALLIET (Lid)
- Ana Laura ANE KOURI (Lid)
- Paulien BAETEN (Lid)
- Bo BATENS (Lid)
- Lien BECKERS (Lid)
- Jeroen BOGIE (Lid)
- Laura BOLKAERTS (Lid)
- Bieke BROUX (Lid)
- Thalissa CAERS (Lid)
- Alessio CARDILLI (Lid)
Projecten
1 - 2 of 2
- Chronische inflammatie en bloed-hersenbarrière verstoring in neurodegeneratieVanaf1 sep 2021 → HedenFinanciering: BOF - tenure track
- Onderzoek in translationele immunomodulatie.Vanaf1 nov 2020 → HedenFinanciering: BOF - ZAP BOF mandaten
Publicaties
41 - 50 van 407
- The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature(2020)
Auteurs: Mark Kacar, Sinisa Savic, Jeroen VAN DER HILST
Pagina's: 141 - 149 - The use of pulse-echo ultrasound in women with a recent non-vertebral fracture to identify those without osteoporosis and/or a subclinical vertebral fracture: a pilot study(2020)
Auteurs: Peter van den Berg, Dave H. Schweitzer, Paul M. M. van Haard, Piet GEUSENS, Joop VAN DEN BERGH
- Osteoporosis care during the COVID-19 pandemic in the Netherlands: A national survey(2021)
Auteurs: Josephine Jeanne Maria Peeters, Peter van den Berg, Joop VAN DEN BERGH, Marielle H. Emmelot-Vonk, Gijs de Klerk, Willem F. Lems, Elizabeth M. Winter, M. Carola Zillikens, Natasha M. Appelman-Dijkstra
- A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service(2022)
Auteurs: Nannan Li, Annelies Boonen, Joop VAN DEN BERGH, Sander M. J. van Kuijk, Caroline E. Wyers, Marsha van Oostwaard, Lisanne Vranken, Sandrine P. G. Bours, Mickael Hiligsmann
Pagina's: 829 - 839 - The pattern of incident fractures according to fracture site in people with T1D(2021)
Auteurs: N. H. Rasmussen, C. Sarodnik, S. P. G. Bours, N. C. Schaper, P. C. Souverein, M. H. Jensen, J. H. M. Driessen, Joop VAN DEN BERGH, P. Vestergaard
Pagina's: 599 - 610 - Stearoyl-CoA desaturase-1 impairs the reparative properties of macrophages and microglia in the brain(2020)
Auteurs: Jeroen BOGIE, Elien GRAJCHEN, Elien WOUTERS, Aida GARCIA CORRALES, Tess DIERCKX, Sam VANHERLE, Jo MAILLEUX, Pascal GERVOIS, Esther WOLFS, Jonas Dehairs, et al.
- A retrospective, multicentre study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) for the treatment of HIV in a real-world setting in Belgium(2022)
Auteurs: R. Nasreddine, E. Florence, J. Yombi, S. Henrard, G. Darcis, J. Van Praet, L. Vandekerckhove, S. Allard, R. Demeester, Peter MESSIAEN, et al.
Pagina's: 116 - 117 - SOLAR 12-month European results: Randomized switch trial of CAB plus RPV vs. oral BIC/FTC/TAF(2023)
Auteurs: I. De Los Santos Gil, A. Ustianowski, G. Orofino, S. Scholten, Peter MESSIAEN, F. Maggiolo, D. Braun, C. Wyen, R. Demeester, C. Jacomet, et al.
Pagina's: 204 - 206 - SCREENING FOR IMMUNOGLOBULIN A ANTIBODY REACTIVITY IN EARLY AXIAL SPONDYLOARTHRITIS IDENTIFIES NOVEL PEPTIDE TARGETS(2021)
Auteurs: Patrick VANDORMAEL, Dana QUADEN, Pieter RUYTINX, Piet GEUSENS, Veerle SOMERS, Johan VANHOOF
Pagina's: 1213 - 1213 - Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS(2023)
Auteurs: Valentina Pegoretti, Jan Bauer, Roman Fischer, Iskra Paro, Wanda Douwenga, Roland E. Kontermann, Klaus Pfizenmaier, Evelien HOUBEN, Bieke BROUX, Niels HELLINGS, et al.